Projects per year
Fingerprint
Dive into the research topics where Thomas Matthew Habermann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
-
-
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
Weiner, G. J., Ansell, S. M., Ballas, Z. K., Bishop, G. A., Cerhan, J. R., Dogan, A. M., Farooq, U., Feldman, A. L., Geyer, S., Gupta, M. D., Habermann, T. M., Hohl, R. J., Houtman, J. C. D., Juweid, M. E., Kaufmann, S. H., Lentz, S. R., Link, B. K., Macon, W. R., Ratliff, T. L., Smith, B. J., Syrbu, S. & Witzig, T. E.
9/11/02 → 6/30/22
Project: Research project
-
C4 - Clinical Research
Ballas, Z. K., Link, B. K. & Habermann, T. M.
10/1/01 → 6/30/12
Project: Research project
-
Eastern Cooperative Oncology Group
Habermann, T. M., Edmonson, J. H., Hahn, R. G. & Habermann, T. M.
6/1/85 → 2/28/14
Project: Research project
-
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome
Chohan, K. L., Young, J. R., Lester, S., Moustafa, M. A., Rosenthal, A., Tun, H. W., Hoppe, B. S., Johnston, P. B., Micallef, I. N., Habermann, T. M. & Ansell, S. M., Jul 26 2022, In: Blood Advances. 6, 14, p. 4241-4250 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A roadmap for clinical trial design in marginal zone lymphoma
Alderuccio, J. P., Habermann, T., Kuker, R., Moskowitz, C. H., Zelenetz, A. D. & Lossos, I. S., Nov 2022, In: American journal of hematology. 97, 11, p. 1398-1403 6 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Tun, A. M., Khurana, A., Mwangi, R., Link, B. K., Wang, Y., Feldman, A. L., Thompson, C. A., Novak, A. J., Villasboas, J. C., Thanarajasingam, G., Farooq, U., Syrbu, S., Nowakowski, G. S., Witzig, T. E., Ansell, S. M., Rimsza, L. M., Cerhan, J. R., Habermann, T. M. & Maurer, M. J., Sep 13 2022, In: Blood Advances. 6, 17, p. 5210-5221 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma
Desai, S. H., Mwangi, R., Smith, A. N., Maurer, M., Farooq, U., King, R., Cerhan, J. R., Feldman, A. L., Habermann, T. M., Thompson, C. A., Wang, Y., Ansell, S. M., Witzig, T. E. & Nowakowski, G. S., 2022, (Accepted/In press) In: Hematological Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
King, R. L., Gupta, A., Kurtin, P. J., Ding, W., Call, T. G., Rabe, K. G., Kenderian, S. S., Leis, J. F., Wang, Y., Schwager, S. M., Slager, S. L., Kay, N. E., Koehler, A., Ansell, S. M., Inwards, D. J., Habermann, T. M., Shi, M., Hanson, C. A., Howard, M. T. & Parikh, S. A., Jan 2022, In: Blood cancer journal. 12, 1, 18.Research output: Contribution to journal › Article › peer-review
Open Access